Press Releases

05.05.2016

WAVE Life Sciences Enters Collaboration with Pfizer to Develop Genetically Targeted Therapies for the Treatment of Metabolic Diseases

05.03.2016

PFIZER REPORTS FIRST-QUARTER 2016 RESULTS

04.28.2016

Pfizer Hosts Annual Meeting of Shareholders

04.26.2016

AM‐Pharma receives FDA fast track designation for recAP in Acute Kidney Injury, and reports completion of first stage in Phase II trial

04.26.2016

Bococizumab SPIRE-2 Cardiovascular Outcome Study Fully Enrolled

04.22.2016

CHANTIX®/CHAMPIX® (varenicline) Results from the Largest Global Clinical Trial of Smoking Cessation Medicines Published in The Lancet

04.21.2016

Pfizer Invites Public to Listen to Webcast of April 28 Annual Meeting of Shareholders

04.19.2016

AM-Pharma STOP-AKI Phase II trial nominated for “Most Innovative Clinical Trial Design” in 2016 CARE Awards

04.19.2016

Pfizer Announces Positive Top-Line Results for Phase 3 PALOMA-2 Clinical Trial of IBRANCE® (palbociclib)

04.07.2016

Pfizer Taps IBM for Research Collaboration to Transform Parkinson’s Disease Care

04.06.2016

Pfizer Receives European Approval for New Multi-Dose Vial Presentation of Prevenar 13®

04.06.2016

Pfizer Announces Termination of Proposed Combination with Allergan